Fang, Yangxin
Chen, Lin
Yuan, Yin
Zhou, Sining
Fu, Jiamin
Zhang, Qi
Zhang, Ning
Huang, Yuqi
Li, Yifei
Yuan, Li
Chen, Lijun
Xiang, Charlie https://orcid.org/0000-0002-9193-3900
Funding for this research was provided by:
the Zhejiang Provincial Natural Science Foundation of China (LTGY24H030002)
the National Key R&D Program of China (2022YFA1105603 2022YFC2304405)
the Fundamental Research Funds for the Central Universities (2025ZFJH03 2022ZFJH003)
the Zhejiang Provincial Key Research and Development Program (2019C03015)
the Shandong Provincial Laboratory Project (SYS202202)
Article History
Received: 12 December 2024
Accepted: 17 April 2025
First Online: 7 May 2025
Declarations
:
: The animal experiments were approved by the Animal Care and Use Committee of Zhejiang University on Dec.04, 2023 (Approval no. ZJU20230279). Human MenSCs (no. 00612-210415P), provided by the Innovative Precision Medicine Group (Hangzhou, China). The Innovative Precision Medicine Group has confirmed that there was initial ethical approval for collection of human cells. And the donor has signed written informed consent.
: Not applicable.
: The authors employed ChatGPT to refine language quality and readability during the manuscript preparation.
: Li Yuan is employee of the Innovative Precision Medicine (IPM) Group. The other authors declare that they have no competing interests.